Literature DB >> 9916105

In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen.

A S MacFarlane1, M G Schwacha, T K Eisenstein.   

Abstract

Our laboratory has previously shown that after immunization with a strain of Salmonella typhimurium, SL3235, made avirulent by a blockage in the pathway of aromatic synthesis, murine splenocytes were profoundly suppressed in their capacity to mount an in vitro antibody plaque-forming cell (PFC) response to sheep erythrocytes. Evidence indicated that suppression was mediated by nitric oxide (NO), since the in vitro addition of NG-monomethyl-L-arginine blocked suppression. The present studies examined the effect of blocking NO production on Salmonella-induced immunosuppression by in vivo administration of aminoguanidine hemisulfate (AG). AG was administered to C3HeB/FeJ mice in their drinking water (2.5% solution) for 7 days prior to intraperitoneal inoculation with SL3235. AG treatment inhibited the increase in nitrate and nitrite levels in plasma and nitrite levels in the spleen seen in immunized mice. Importantly, AG treatment completely blocked suppression of the splenic PFC response and markedly attenuated the suppression of the response to concanavalin A in immunized mice, providing further evidence that Salmonella-induced immunosuppression is mediated by NO. AG treatment also alleviated the majority of the splenomegaly associated with SL3235 inoculation, which correlated with a blockage of influx of neutrophils and macrophages into spleens, as assessed by flow cytometry. AG treatment unexpectedly resulted in 90% mortality in mice injected with the highly attenuated vaccine strain of Salmonella, SL3235. Increased mortality in AG-treated mice correlated with inability to clear organisms from the spleen by day 15 postinoculation and with persistent bacteremia, compared with control mice. Collectively, these in vivo results underscore the dual biological consequences of NO production following Salmonella infection, with NO being necessary for host defense, but also having the potentially adverse effect of immunosuppression. A unifying hypothesis to explain how these seemingly paradoxical effects could both result from NO production is presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916105      PMCID: PMC96401     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages.

Authors:  F Y Liew; Y Li; D Moss; C Parkinson; M V Rogers; S Moncada
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

2.  Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression.

Authors:  B K al-Ramadi; J M Greene; J J Meissler; T K Eisenstein
Journal:  Microb Pathog       Date:  1992-04       Impact factor: 3.738

3.  Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.

Authors:  L S Anthony; P J Morrissey; F E Nano
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

4.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.

Authors:  L B Adams; S G Franzblau; Z Vavrin; J B Hibbs; J L Krahenbuhl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

5.  Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1991-04       Impact factor: 4.962

6.  Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.

Authors:  M A Muñoz-Fernández; M A Fernández; M Fresno
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

7.  Immunosuppression induced by nitric oxide and its inhibition by interleukin-4.

Authors:  B K al-Ramadi; J J Meissler; D Huang; T K Eisenstein
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

8.  Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.

Authors:  H H Schmidt; T D Warner; M Nakane; U Förstermann; F Murad
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

9.  Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei.

Authors:  P Vincendeau; S Daulouède; B Veyret; M L Darde; B Bouteille; J L Lemesre
Journal:  Exp Parasitol       Date:  1992-11       Impact factor: 2.011

10.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.

Authors:  J Chan; Y Xing; R S Magliozzo; B R Bloom
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  34 in total

1.  Host response to a dam mutant of Salmonella enterica serovar enteritidis with a temperature-sensitive phenotype.

Authors:  Mónica N Giacomodonato; Sebastián H Sarnacki; Roberto L Caccuri; Daniel O Sordelli; M Cristina Cerquetti
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Salmonella inhibit T cell proliferation by a direct, contact-dependent immunosuppressive effect.

Authors:  Adrianus W M van der Velden; Michael K Copass; Michael N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

3.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

4.  Characterization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection.

Authors:  Hans-Willi Mittrücker; Anne Köhler; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Nitric oxide and apoptosis induced in Peyer's patches by attenuated strains of Salmonella enterica serovar Enteritidis.

Authors:  M C Cerquetti; N B Goren; A J Ropolo; D Grasso; M N Giacomodonato; M I Vaccaro
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments.

Authors:  Carmen M Collazo; George S Yap; Sara Hieny; Patricia Caspar; Carl G Feng; Gregory A Taylor; Alan Sher
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.

Authors:  M G Schwacha; J J Meissler; T K Eisenstein
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection.

Authors:  Tanner M Johanns; James M Ertelt; Jared H Rowe; Sing Sing Way
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 9.  Membrane tubulovesicular extensions (cytonemes): secretory and adhesive cellular organelles.

Authors:  Svetlana I Galkina; Natalia V Fedorova; Vladimir I Stadnichuk; Galina F Sud'ina
Journal:  Cell Adh Migr       Date:  2013-01-03       Impact factor: 3.405

10.  Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.

Authors:  Karla Simone S Fernandes; Edward Helal Neto; Marcelly M S Brito; João S Silva; Fernando Q Cunha; Christina Barja-Fidalgo
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.